The Effects of Inhalation of a Novel Nitric Oxide Donor, DETA/NO, in a Patient with Severe Hypoxaemia Due to Acute Respiratory Distress Syndrome

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Anaesthesia and Intensive Care

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0310057X0203000413PMID 12180587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension

  2001cited by this paper
• The acute respiratory distress syndrome.

  2000cited by this paper
• Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS.

  2000cited by this paper
• Diazeniumdiolates: pro- and antioxidant applications of the "NONOates".

  2000cited by this paper
• Inhaled and exhaled nitric oxide

  1999cited by this paper
• Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

  1998cited by this paper
• Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension.

  1996cited by this paper
• Recovery of function in survivors of the acute respiratory distress syndrome.

  1994cited by this paper
• Predicting the presence of pulmonary function impairment in adult respiratory distress syndrome survivors.

  1993cited by this paper

• Development of Antimicrobial Nitric Oxide-Releasing Fibers

  2021cites this paper
• Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents.

  2019cites this paper
• Polyamines – A New Metabolic Switch: Crosstalk With Networks Involving Senescence, Crop Improvement, and Mammalian Cancer Therapy

  2019cites this paper
• Fe-S Clusters Emerging as Targets of Therapeutic Drugs

  2017cites this paper
• Nitric oxide generating/releasing materials

  2015cites this paper
• Dinitrosyl Iron Complexes and their Role in Patho-physiological Conditions

  2011cites this paper
• Modulating the NO generating system from a medicinal chemistry perspective: current trends and therapeutic options in cardiovascular disease.

  2010cites this paper
• Nitric Oxide Inhibits Tumor Cell Metastasis via Dysregulation of the NF-κB/Snail/RKIP Loop

  2010cites this paper
• Medicinal Chemistry and Therapeutic Applications of the Gasotransmitters NO, CO, and H2S and their Prodrugs

  2010cites this paper
• Diazeniumdiolate reactivity in model membrane systems.

  2008cites this paper
• The nitric oxide/cGMP signaling pathway in pulmonary hypertension.

  2007cites this paper
• Recent developments in nitric oxide donor drugs

  2007cites this paper
• Future Drugs for Treatment of Acute Respiratory Distress Syndrome

  2005cites this paper
• The selective pulmonary vasodilatory effect of inhaled DETA/NO, a novel nitric oxide donor, in ARDS-a pilot human trial.

  2004cites this paper
• Diethylenetriamine NITRIC oxide adduct relaxes precontracted mouse tracheal smooth muscle *

  2003cites this paper
• Intravenous and Intrapulmonary Administration of Honey Solution to Healthy Sheep: Effects on Blood Sugar, Renal and Liver Function Tests, Bone Marrow Function, Lipid Profile, and Carbon Tetrachloride-Induced Liver Injury

  2003cites this paper
• Two aerosolized nitric oxide adducts as selective pulmonary vasodilators for acute pulmonary hypertension.

  2003cites this paper
• Obstetric and gynaecological anaesthesia

  2003cites this paper
• Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates.

  2003cites this paper
• Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory fl

  2003cites this paper
• Recent advances in the treatment of pulmonary hypertension

  2003cites this paper
• Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators

  2002cites this paper